Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Rectal Neoplasms 13Breast Neoplasms 12Colorectal Neoplasms 11Colonic Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 9Carcinoma, Non-Small-Cell Lung 9Leukemia, Myeloid, Acute 8Carcinoma, Renal Cell 8Prostatic Neoplasms 7Lung Neoplasms 7Kidney Neoplasms 7Multiple Myeloma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Gliosarcoma 6Glioblastoma 6Esophageal Neoplasms 6Congenital Abnormalities 6Stomach Neoplasms 5Melanoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Leukemia, Lymphocytic, Chronic, B-Cell 5Central Nervous System Neoplasms 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Myelodysplastic Syndromes 4Lymphoma, Large-Cell, Immunoblastic 4

Interventions

Doxorubicin 20Vincristine 17Zidovudine 13Cyclophosphamide 12Bleomycin 12Etoposide 10Rituximab 6Prednisone 6Interferon alpha-2 6Cytarabine 6Liposomes 5Filgrastim 5Dexamethasone 5tecogalan 4sargramostim 4Specimen Handling 4Methotrexate 4Magnetic Resonance Spectroscopy 4Leucovorin 4Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4Fluorouracil 4Biopsy 4Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Nivolumab 3interferon alfa-n1 2fludarabine phosphate 2fludarabine 2cabozantinib 2Whole-Body Irradiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × HIV Infections × Gene Expression Profiling × Clear all
NCT00686842 2018-06-06

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 1/2 Terminated
17 enrolled 7 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡